SAILIFE · Health Care · 2026-08-21
Sai Life Sciences Ltd
8.8★★★ PrimeStrong +13.2Stage 2 · wk 25In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,457.4
-0.96% today
₹30,943 Cr · Large cap
About this companyHealth Care· BiotechnologyExpand ▾
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Visit company website →P/E (TTM)
68.8
Forward 46.1
Earnings Growth (YoY)
+17.6%
Revenue +3.9%
ROE
+15.1%
Profit margin +15.9%
vs 52W High
-1.0%
₹795 lo₹1,471.6 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 25
1w13w26w
Week 25 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
38.9%
200 DMA: ₹1,049.2 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.68x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +6.8% vs MA50 +8.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #16 of 84 Stage 2 stocks in Health Care by RS.
Industry
Biotechnology
Stage 2%
57.1%
20d Δ
-14.3pp
1M return
+2.4%
3M return
+6.5%
Industry Stage-2 % · last 20 days
Ranks #1 of 4 Stage 2 stocks in this industry. Top stock in industry.
Price + Volume Chart
1M
+17.5%
3M
+30.8%
6M
+58.3%
YTD
+64.4%
1Y
+61.4%
Moving averages & range
50 DMA
₹1,300.3
200 DMA
₹1,049.2
52W High
₹1,471.6
52W Low
₹795
5D Low
₹1,416.4
Resistance levels (recent highs)
20d High
₹1,471.6
60d High
₹1,471.6
120d High
₹1,471.6
250d High
₹1,471.6
Next resistance
+1.0%
to 20d High
All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.